Countouriotis Athena 4
4 · IOVANCE BIOTHERAPEUTICS, INC. · Filed Jun 13, 2024
Insider Transaction Report
Form 4
Countouriotis Athena
Director
Transactions
- Award
Deferred Restricted Stock Unit
2024-06-11+49,303→ 49,303 total→ Common Stock (49,303 underlying)
Footnotes (2)
- [F1]Each deferred restricted stock unit ("DRSU") represents a contingent right to receive one share of the Issuer's common stock and are granted pursuant to the Issuer's 2018 Equity Incentive Plan (as amended).
- [F2]Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (2) the day prior to the Issuer's next annual shareholder meeting. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reported Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date.